Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Use of statins after liver transplantation is associated with improved survival: results of a nationwide study
Chiara Becchetti, Melisa Dirchwolf, Jonas Schropp, et al.
Alimentary Pharmacology & Therapeutics (2022) Vol. 56, Iss. 7, pp. 1194-1204
Open Access | Times Cited: 25

Showing 25 citing articles:

Gp78 deficiency in hepatocytes alleviates hepatic ischemia-reperfusion injury via suppressing ACSL4-mediated ferroptosis
Changbiao Li, Yichao Wu, Kangchen Chen, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 14
Evaluation of Lipid Management Practices for Secondary Atherosclerotic Cardiovascular Disease Prevention in Abdominal Solid Organ Transplant Recipients
Kennedy Concannon, Zachary Bentz, Sarah Kokosa, et al.
Journal of clinical lipidology (2025)
Closed Access
Challenges in the management of MetALD after liver transplantation
M. Cucco, Chiara Becchetti, Miki Scaravaglio, et al.
Metabolism and Target Organ Damage (2025) Vol. 5, Iss. 1
Open Access
Statin Use in Special Populations for the Prevention of Cardiovascular Disease in Adults
Maya Safarova, Spencer F. Weintraub, Katherine Sadaniantz, et al.
Current Atherosclerosis Reports (2025) Vol. 27, Iss. 1
Closed Access
Atherosclerosis on CT coronary angiography and the risk of long-term cardiovascular events after liver transplantation
Thalys Sampaio Rodrigues, A. Koshy, Paul Gow, et al.
Liver Transplantation (2023) Vol. 30, Iss. 2, pp. 182-191
Closed Access | Times Cited: 7
Mechanisms and implications of recompensation in cirrhosis
Salvatore Piano, Thomas Reiberger, Jackie Bosch
JHEP Reports (2024) Vol. 6, Iss. 12, pp. 101233-101233
Open Access | Times Cited: 2
The Impact of Metabolic Health and Obesity on Liver Transplant Candidates and Recipients
Alexander S. Vogel, Rebecca Roediger, Dagny Von Ahrens, et al.
Life (2024) Vol. 14, Iss. 6, pp. 685-685
Open Access | Times Cited: 1
Statin, aspirin and metformin use and risk of hepatocellular carcinoma related outcomes following liver transplantation: A retrospective study
William Chung, Kevin Wong, Noel Ravindranayagam, et al.
World Journal of Transplantation (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 1
Statin therapy: improving survival in patients with hepatocellular carcinoma and portal hypertension is possible?
Giulia Dispinzieri, Chiara Becchetti, Chiara Mazzarelli, et al.
Acta Gastro Enterologica Belgica (2024) Vol. 87, Iss. 3, pp. 395-402
Closed Access | Times Cited: 1
Lipid disorders before and after successful liver transplantation
Damian Gojowy, Joanna Urbaniec-Stompór, Joanna Adamusik, et al.
Acta Biochimica Polonica (2023)
Open Access | Times Cited: 3
Effect of statins on the recurrence of hepatocellular carcinoma after liver transplantation: An illusion revealed by exposure density sampling
Deok Gie Kim, Seung Hyuk Yim, Eun‐Ki Min, et al.
Liver International (2023) Vol. 43, Iss. 9, pp. 2017-2025
Closed Access | Times Cited: 2
Minimizing Metabolic and Cardiac Risk Factors to Maximize Outcomes After Liver Transplantation
Kathryn Schmidt, Ashley Spann, Qasim Khan, et al.
Transplantation (2023)
Closed Access | Times Cited: 1
Statins in Chronic Liver Disease: Review of the Literature and Future Role
Nguyen C. Pham, Jihane N. Benhammou
Seminars in Liver Disease (2024) Vol. 44, Iss. 02, pp. 191-208
Closed Access
Treatment of Hyperlipidemia With Alirocumab in a Liver Transplant Recipient With Poor Blood Lipid Control: Case Report
Tieyan Fan, Yan Yan, Qian Lü, et al.
Transplantation Proceedings (2024) Vol. 56, Iss. 5, pp. 1169-1172
Closed Access
Metabolic Steatohepatitis After Liver Transplantation
Alberto Ferrarese, Sara Battistella, Francesco Paolo Russo, et al.
(2024), pp. 161-170
Closed Access
Letter: what explains improved survival from statin exposure after liver transplantation?
Guang‐Peng Zhou, Yizhou Jiang, Li‐Ying Sun, et al.
Alimentary Pharmacology & Therapeutics (2022) Vol. 56, Iss. 10, pp. 1507-1508
Open Access | Times Cited: 1
Protective effect of low-dose aspirin against acute cellular allograft rejection after primary liver transplantation
Guang‐Peng Zhou, Yizhou Jiang, Li‐Ying Sun, et al.
Liver Transplantation (2023) Vol. 29, Iss. 4, pp. E3-E4
Open Access
Reply
Christian E. Oberkofler, Dimitri A. Raptis, Henrik Petrowsky
Liver Transplantation (2023) Vol. 29, Iss. 4, pp. E5-E5
Open Access
Comment to “Donor Simvastatin Treatment in Liver Transplantation: Post-hoc Analysis of a Randomized Placebo-controlled Trial With Long-term Follow-up”
Duilio Pagano, Salvatore Gruttadauria
Transplantation (2023) Vol. 107, Iss. 4, pp. e124-e124
Open Access
Adesão ao tratamento imunossupressor: avaliação comparativa entre diferentes fases do pós-transplante hepático
Katherine Xavier Bastos, Gabriel Alencar Accioly, Paulo Sérgio Dourado Arrais
Revista Eletrônica Acervo Saúde (2023) Vol. 23, Iss. 8, pp. e13320-e13320
Open Access
Use of statins after liver transplantation is associated with improved survival: results of a nationwide study
Chiara Becchetti, Melisa Dirchwolf, Jonas Schropp, et al.
Journal of Hepatology (2022) Vol. 77, pp. S780-S780
Open Access
Letter: what explains improved survival from statin exposure after liver transplantation? Authors' reply
Chiara Becchetti, Melisa Dirchwolf, Jonas Schropp, et al.
Alimentary Pharmacology & Therapeutics (2022) Vol. 56, Iss. 10, pp. 1509-1510
Open Access
Letter: PCSK9 inhibitor for liver transplant patients during the post‐statin era?
Jiamei Wang, Jia Wu, Zhiqing He, et al.
Alimentary Pharmacology & Therapeutics (2022) Vol. 57, Iss. 1, pp. 185-186
Open Access
Letter: PCSK9 inhibitor for liver transplant patients during the post‐statin era? Authors' reply
Chiara Becchetti, Melisa Dirchwolf, Annalisa Berzigotti, et al.
Alimentary Pharmacology & Therapeutics (2022) Vol. 57, Iss. 1, pp. 187-188
Open Access
Page 1

Scroll to top